ALDX
Aldeyra Therapeutics, Inc.
1.20$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -2,092.8% | – | – | – | – | – | – | – | – | – | – | |
| – | +2.3% | -8.8% | +1.6% | +2.2% | +2.2% | -5.4% | +2.2% | +2.2% | +2.3% | +2.3% | +6.2% | – | |
| – | -201.4% | – | +25.0% | +66.7% | -60.8% | +76.0% | -91.2% | +1,212.9% | -57.8% | -190.6% | – | – | |
| – | – | -157.2% | – | +104.4% | -33.7% | -265.8% | – | -232.2% | – | -117,021.7% | – | – | |
| – | -100.0% | – | -33.3% | +0.0% | -100.0% | – | – | – | -100.0% | – | +2,309,700.0% | – | |
| – | – | – | -40.0% | – | -129.7% | – | -107.6% | – | -36.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +220.6% | – | -100.0% | – | – | +12,791.2% | +99,999,800.0% | -100.0% | -1,661,022,406.3% | – | -21,606.9% | – | |
| – | – | – | – | – | – | – | – | – | -40.9% | -147.1% | – | – | |
| – | – | -2,092.8% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.